semaglutide canada patent The story: highlighting the need to maintain protection in Experts are sounding the alarm!

First-line treatments, such as low-dose aspirin and goal-directed phlebotomy to a hematocrit level of less than 45% to reduce thrombotic events, improve quality of life and prolong survival

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on Thursday ahead of a major medical meeting.

#Wegovy, on the other hand, is what we reach for when obesity is the primary concern and diabetes is either not present or a secondary issue

Connecticut Department of Social Services Andrea Barton Reeves Ned Lamont Matthew Lesser Novo Nordisk Eli Lilly and Company Nathan Tinker Connecticut Pharmacists Association Maysoon Khan Connecticut Public #CTHealthNews #GLP1 #WeightManagement #HealthcarePolicy #PrescriptionDrugs #ConnecticutNews

Explore the impact of GLP-1 meds like Ozempic on eating disorders